The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Nodal proteins are target antigens in Guillain‐Barré syndrome
Abstract
Neurofascin‐186 (NF186), neuronal cell adhesion molecule (NrCAM), and gliomedin are adhesion molecules playing a central role in the formation of nodes of Ranvier. In Guillain‐Barré syndrome (GBS), immune attack toward the nodes may participate in the disabilities. Autoantibodies to NF186 and gliomedin have been detected in a rat model of GBS. Here, we investigated the prevalence of antibodies against nodal adhesion molecules in patients with GBS or chronic inflammatory demyelinating polyneuropathy (CIDP). Sera from 100 GBS patients, 50 CIDP patients, 80 disease controls, and 50 healthy controls were tested for their ability to bind the nodes of Ranvier. To characterize the antigens, we performed cell binding assays against NF186, gliomedin, contactin, and NrCAM. We found that 43% of patients with GBS and 30% of patients with CIDP showed IgG fixation at nodes or paranodes. In eight patients with GBS or CIDP, we identified that IgG antibodies recognized the native extracellular domain of NF186, gliomedin, or contactin. Also, 29 patients showed IgM against nodal adhesion molecules. However, we did not detect IgM fixation at nodes or paranodes. Antibodies to gliomedin or NF186 were mostly detected in demyelinating and axonal GBS, respectively. The adsorption of the antibodies to their soluble antigens abolished IgG deposition at nodes and paranodes in nerves, indicating these were specific to NF186, gliomedin, and contactin. In conclusion, gliomedin, NF186, and contactin are novel target antigens in GBS. At nodes, additional epitopes are also the targets of IgG. These results suggest that antibody attack against nodal antigens participates in the etiology of GBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peripheral neuropathies and anti-glycolipid antibodies
Willison, H. J. (2002) · Brain · doi:10.1093/brain/awf272 · Cited by 710
Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier
Eshed, Y., Feinberg, K., Poliak, S., Sabanay, H., Sarig-Nadir, O., Spiegel, I., Bermingham, J. R., & Peles, E. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.026 · Cited by 321 · cited 4×
“…are target antigens in GBS patients Recent genetic investigations identified the constituents of the axoglial junctions at nodes and paranodes (Bhat et al., 2001; Boyle et al., 2001; Charles et al., 2002; Eshed et al., 2005; Zonta et al., 2008; Feinberg et al., 2010; Thaxton et al., 2011).”
BackgroundMethodInfluentialZonta, B., Tait, S., Melrose, S., Anderson, H., Harroch, S., Higginson, J., Sherman, D. L., & Brophy, P. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200712154 · Cited by 188 · cited 6×
“Recent genetic investigations identified the constituents of the axoglial junctions at nodes and paranodes (Bhat et al., 2001; Boyle et al., 2001; Charles et al., 2002; Eshed et al., 2005; Zonta et al., 2008; Feinberg et al., 2010; Thaxton et al., 2011).”
BackgroundInfluential
Cited by
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
Mathey, E. K., Park, S. B., Hughes, R. A. C., Pollard, J. D., Armati, P. J., Barnett, M. H., Taylor, B. V., Dyck, P. J. B., Kiernan, M. C., & Lin, C. S.-Y. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309697 · Cited by 440
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg
Querol, L., Nogales-Gadea, G., Rojas-Garcia, R., Diaz-Manera, J., Pardo, J., Ortega-Moreno, A., Sedano, M. J., Gallardo, E., Berciano, J., Blesa, R., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000205 · Cited by 370
Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy
Querol, L., Nogales‐Gadea, G., Rojas‐Garcia, R., Martinez‐Hernandez, E., Diaz‐Manera, J., Suárez‐Calvet, X., Navas, M., Araque, J., Gallardo, E., & Illa, I. (2013) · Annals of Neurology · doi:10.1002/ana.23794 · Cited by 352
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome
Keddie, S., Pakpoor, J., Mousele, C., Pipis, M., Machado, P. M., Foster, M., Record, C. J., Keh, R. Y. S., Fehmi, J., Paterson, R. W., et al. (2021) · Brain · doi:10.1093/brain/awaa433 · Cited by 333
The Nodes of Ranvier: Molecular Assembly and Maintenance
Rasband, M. N., & Peles, E. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020495 · Cited by 190
“Maintaining the exquisite molecular organization of myelinated axons, and particularly the nodal environ is of interest given the presence of autoantibodies to nodal CAMs in Guillain–Barre syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multiple sclerosis (Mathey et al. 2007; Pruss et al.…”
Background
Metadata
- Authors
- Devaux, J. J., Odaka, M., & Yuki, N.
- Venue
- Journal of the Peripheral Nervous System
- Publisher
- Wiley
- Published
- 2012-03
- Volume
- 17
- Issue
- 1
- Pages
- 62-71
- ISSN
- 1085-9489 (ISSN-L)
- 1529-8027
- OpenAlex
- W2020510864
- Cited by
- 193
- References
- 3
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.